Men with enlarged prostates offered robotic treatment by fourth University Hospital
Aquablation is a robotic method that uses a high-pressure saline solution to remove tissue
Read Moreby John Pinching | Aug 18, 2023 | News | 0
Aquablation is a robotic method that uses a high-pressure saline solution to remove tissue
Read Moreby John Pinching | Jul 17, 2023 | News | 0
OCTP develops cannabinoid medicines and is looking at potential treatment of cancer malignancies
Read Moreby John Pinching | Sep 9, 2022 | News | 0
Company is introducing abiraterone film-coated tablets for treating metastatic prostate cancer
Read Moreby John Pinching | Jul 11, 2022 | News | 0
Data shows a significant reduction in treated spontaneous and traumatic bleeds among haemophilia patients
Read Moreby John Pinching | Jul 5, 2022 | News | 0
Treatment abstract focuses on results from a multiple ascending dose study in healthy volunteers
Read Moreby John Pinching | Apr 27, 2022 | News | 0
MMM is a global campaign which raises awareness of high blood pressure and its long-term implications
Read Moreby John Pinching | Apr 22, 2022 | News | 0
Researchers were able to detect specific combinations of genetic alterations which may hold key to the growth of cancers
Read Moreby Selina McKee | Jun 10, 2020 | News | 0
The NHS Confederation also warns that ‘it will not be possible to simply ‘switch on’ NHS services immediately’
Read Moreby Anna Smith | Feb 17, 2020 | News | 0
PKU is a rare, inherited metabolic disorder that affects approximately 70 babies each year in the UK.
Read Moreby Anna Smith | Feb 13, 2020 | News | 0
The GenesisCare technology is part of a £20m investment.
Read Moreby Anna Smith | Oct 15, 2019 | News | 0
The process could pave the way for more rapid delivery of individualised treatments.
Read Moreby Anna Smith | Jul 29, 2019 | News | 0
Scientists are “re-imagining ultrasound technology to develop a treatment that can liquefy cancer cells in the body using microscopic bubbles”.
Read More




PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
